Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice - PubMed (original) (raw)
. 2005 Aug 1;14(15):2167-80.
doi: 10.1093/hmg/ddi221. Epub 2005 Jun 22.
Affiliations
- PMID: 15972724
- DOI: 10.1093/hmg/ddi221
Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice
Leslie C Mounkes et al. Hum Mol Genet. 2005.
Abstract
The nuclear lamina is an approximately 10 nm thick proteinaceous layer underlying the inner nuclear membrane. The A-type lamins, nuclear intermediate filament proteins encoded by the LMNA gene, are basic components of the nuclear lamina. Mutations in LMNA are associated with the laminopathies, congenital diseases affecting tissue regeneration and homeostasis. One of these laminopathies associated with missense mutations in LMNA is dilated cardiomyopathy with conduction system disease (DCM-CD1). To understand how the laminopathies arise from different mutations in a single gene, we derived a mouse line by homologous recombination expressing the Lmna-N195K variant of the A-type lamins with an asparagine-to-lysine substitution at amino acid 195, which causes DCM in humans. This mouse line shows characteristics consistent with DCM-CD1. Continuous electrocardiographic monitoring of cardiac activity demonstrated that LmnaN195K/N195K mice die at an early age due to arrhythmia. By immunofluorescence and western analysis, the transcription factor Hf1b/Sp4 and the gap junction proteins connexin 40 and connexin 43 were misexpressed and/or mislocalized in LmnaN195K/N195K hearts. Desmin staining revealed a loss of organization at sarcomeres and intercalated disks. Mutations within the LMNA gene may therefore cause cardiomyopathy by disrupting the internal organization of the cardiomyocyte and/or altering the expression of transcription factors essential to normal cardiac development, aging or function.
Similar articles
- Inhibition of late sodium current attenuates ionic arrhythmia mechanism in ventricular myocytes expressing LaminA-N195K mutation.
Markandeya YS, Tsubouchi T, Hacker TA, Wolff MR, Belardinelli L, Balijepalli RC. Markandeya YS, et al. Heart Rhythm. 2016 Nov;13(11):2228-2236. doi: 10.1016/j.hrthm.2016.08.007. Epub 2016 Aug 3. Heart Rhythm. 2016. PMID: 27498076 - Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies.
Arimura T, Helbling-Leclerc A, Massart C, Varnous S, Niel F, Lacène E, Fromes Y, Toussaint M, Mura AM, Keller DI, Amthor H, Isnard R, Malissen M, Schwartz K, Bonne G. Arimura T, et al. Hum Mol Genet. 2005 Jan 1;14(1):155-69. doi: 10.1093/hmg/ddi017. Epub 2004 Nov 17. Hum Mol Genet. 2005. PMID: 15548545 - High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
van Tintelen JP, Hofstra RM, Katerberg H, Rossenbacker T, Wiesfeld AC, du Marchie Sarvaas GJ, Wilde AA, van Langen IM, Nannenberg EA, van der Kooi AJ, Kraak M, van Gelder IC, van Veldhuisen DJ, Vos Y, van den Berg MP; Working Group on Inherited Cardiac Disorders, line 27/50, Interuniversity Cardiology Institute of The Netherlands. van Tintelen JP, et al. Am Heart J. 2007 Dec;154(6):1130-9. doi: 10.1016/j.ahj.2007.07.038. Epub 2007 Sep 14. Am Heart J. 2007. PMID: 18035086 - [Diseases associated with lamin A/C gene defects: what the clinical cardiologist ought to know].
Pasotti M, Repetto A, Pisani A, Arbustini E. Pasotti M, et al. Ital Heart J Suppl. 2004 Feb;5(2):98-111. Ital Heart J Suppl. 2004. PMID: 15080529 Review. Italian. - Nuclear lamins, diseases and aging.
Mattout A, Dechat T, Adam SA, Goldman RD, Gruenbaum Y. Mattout A, et al. Curr Opin Cell Biol. 2006 Jun;18(3):335-41. doi: 10.1016/j.ceb.2006.03.007. Epub 2006 Apr 24. Curr Opin Cell Biol. 2006. PMID: 16632339 Review.
Cited by
- The Pathogenic Mechanisms of and Novel Therapies for Lamin A/C-Related Dilated Cardiomyopathy Based on Patient-Specific Pluripotent Stem Cell Platforms and Animal Models.
Wu XY, Lee YK, Lau YM, Au KW, Tse YL, Ng KM, Wong CK, Tse HF. Wu XY, et al. Pharmaceuticals (Basel). 2024 Aug 5;17(8):1030. doi: 10.3390/ph17081030. Pharmaceuticals (Basel). 2024. PMID: 39204134 Free PMC article. Review. - Genetic and Pathophysiological Basis of Cardiac and Skeletal Muscle Laminopathies.
Bhide S, Chandran S, Rajasekaran NS, Melkani GC. Bhide S, et al. Genes (Basel). 2024 Aug 20;15(8):1095. doi: 10.3390/genes15081095. Genes (Basel). 2024. PMID: 39202453 Free PMC article. Review. - Microtubule forces drive nuclear damage in LMNA cardiomyopathy.
Pavlov DA, Heffler J, Suay-Corredera C, Dehghany M, Shen KM, Zuela-Sopilniak N, Randell R, Uchida K, Jain R, Shenoy V, Lammerding J, Prosser B. Pavlov DA, et al. bioRxiv [Preprint]. 2024 Oct 5:2024.02.10.579774. doi: 10.1101/2024.02.10.579774. bioRxiv. 2024. PMID: 38948795 Free PMC article. Preprint. - Eliminating elevated p53 signaling fails to rescue skeletal muscle defects or extend survival in lamin A/C-deficient mice.
Kirby TJ, Zahr HC, Fong EHH, Lammerding J. Kirby TJ, et al. Cell Death Discov. 2024 May 22;10(1):245. doi: 10.1038/s41420-024-01998-1. Cell Death Discov. 2024. PMID: 38778055 Free PMC article. - Global Proteomic Analysis Reveals Alterations in Differentially Expressed Proteins between Cardiopathic Lamin A/C Mutations.
Anderson CL, Brown KA, North RJ, Walters JK, Kaska ST, Wolff MR, Kamp TJ, Ge Y, Eckhardt LL. Anderson CL, et al. J Proteome Res. 2024 Jun 7;23(6):1970-1982. doi: 10.1021/acs.jproteome.3c00853. Epub 2024 May 8. J Proteome Res. 2024. PMID: 38718259 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous